Chalid Assaf, Gabor Dobos, Max Schlaak, Nina Booken, Mathias Oymanns, Kai-Christian Klespe, Jan Nicolay, Marion Wobser, Lennart Ocker, Sebastian Haferkamp, Patrick Terheyden, Carsten Weishaupt, Christian Menzer, Claus-Detlev Klemke, Johannes Wohlrab, Marlene Garzarolli, Oana-Diana Persa, Ulrich Wehry, Edgar Dippel, Andreas Bachinger, Azeem Danish
{"title":"德国“Mogamulizumab在非介入研究中评估蕈样真菌病和ssamzary综合征治疗的安全性和结果”(MINT)研究的最新中期结果","authors":"Chalid Assaf, Gabor Dobos, Max Schlaak, Nina Booken, Mathias Oymanns, Kai-Christian Klespe, Jan Nicolay, Marion Wobser, Lennart Ocker, Sebastian Haferkamp, Patrick Terheyden, Carsten Weishaupt, Christian Menzer, Claus-Detlev Klemke, Johannes Wohlrab, Marlene Garzarolli, Oana-Diana Persa, Ulrich Wehry, Edgar Dippel, Andreas Bachinger, Azeem Danish","doi":"10.1016/j.ejca.2025.115891","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"229 ","pages":""},"PeriodicalIF":7.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Updated interim results from the German “Mogamulizumab In a Non-interventional study to evaluate the safety and outcome in mycosis fungoides and Sézary syndrome Treatment” (MINT) study\",\"authors\":\"Chalid Assaf, Gabor Dobos, Max Schlaak, Nina Booken, Mathias Oymanns, Kai-Christian Klespe, Jan Nicolay, Marion Wobser, Lennart Ocker, Sebastian Haferkamp, Patrick Terheyden, Carsten Weishaupt, Christian Menzer, Claus-Detlev Klemke, Johannes Wohlrab, Marlene Garzarolli, Oana-Diana Persa, Ulrich Wehry, Edgar Dippel, Andreas Bachinger, Azeem Danish\",\"doi\":\"10.1016/j.ejca.2025.115891\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11980,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"229 \",\"pages\":\"\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0959804925007208\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804925007208","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Updated interim results from the German “Mogamulizumab In a Non-interventional study to evaluate the safety and outcome in mycosis fungoides and Sézary syndrome Treatment” (MINT) study
期刊介绍:
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.